IBM vs IMVT · P/E 25, rev $17.16B vs $2.90B cap
International Business Machines (IBM) versus Immunovant Inc (IMVT) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Immunovant Inc (IMVT) is a biotechnology company listed on US.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
IMVT does not have a complete income-statement cache yet.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. IMVT currently screens at market cap $2.90B.
Not investment advice. Open the IBM and IMVT stock pages for the full models.
Not investment advice.